AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2022 | Series Unknown | £2.45M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ascension Life Fund | — | Series Unknown |